
11 - 50 employees
Founded 2017
𧬠Biotechnology
π€ Artificial Intelligence
π Pharmaceuticals
π° $3.1M Post-IPO Equity - BullFrog AI on 2024-10
Biotechnology β’ Artificial Intelligence β’ Pharmaceuticals
BullFrog AI is an AI-driven life sciences company that builds platforms to transform raw, fragmented biomedical data into clean, harmonized, AI-ready assets and to generate biological insight for drug discovery. Its products include bfPREP, an AI-powered data preparation platform for clinical trial, multi-omics, and clinical datasets, and bfLEAP, an AI/ML multi-omics insight platform that identifies patient subgroups, biomarkers, novel drug targets, and disease mechanisms. The company also highlights a CNS target-discovery drug pipeline and tools to support indication selection, trial design, and portfolio prioritization.
π₯ 4 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2017
𧬠Biotechnology
π€ Artificial Intelligence
π Pharmaceuticals
π° $3.1M Post-IPO Equity - BullFrog AI on 2024-10
Biotechnology β’ Artificial Intelligence β’ Pharmaceuticals
BullFrog AI is an AI-driven life sciences company that builds platforms to transform raw, fragmented biomedical data into clean, harmonized, AI-ready assets and to generate biological insight for drug discovery. Its products include bfPREP, an AI-powered data preparation platform for clinical trial, multi-omics, and clinical datasets, and bfLEAP, an AI/ML multi-omics insight platform that identifies patient subgroups, biomarkers, novel drug targets, and disease mechanisms. The company also highlights a CNS target-discovery drug pipeline and tools to support indication selection, trial design, and portfolio prioritization.
β’ Own the evidence that establishes a ranking is right β’ Decide what each ranking gets compared against β’ Bring the scientific grounding to label design β’ Ensure any ranking that leaves the building can be defended to a scientist β’ Support commercial and product teams in label investment decisions
β’ PhD in computational biology, bioinformatics, genetics, systems biology, or a closely related quantitative field β’ 5+ years in a relevant field, designing evaluations for ambiguous problems β’ Deep knowledge of functional genomics or disease biology β’ Proficiency in Python β’ Must be legally authorized to work in the United States
β’ Full benefits from day one including medical, dental, and vision coverage β’ Short-term disability β’ 401(k) enrollment β’ 15 days of paid time off annually plus 11 paid holidays annually β’ Maternity and paternity leave
Apply Nowπ₯ 4 hours ago
Industry Principal managing overall strategy and execution for life sciences. Collaborating across marketing, sales, and engineering in a remote setting with travel requirements.
π₯ 7 hours ago
Principal responsible for leading strategies to win new business for Danaher by selling outcomes-based partnership models. Collaborating with senior hospital executives to create impactful diagnostic solutions.
π₯ 7 hours ago
Principal Specialist at RTX developing export authorization strategies and managing compliance in global trade licensing. Working with cross-functional teams to support international procurement and manufacturing.
πΊπΈ United States β Remote
π΅ $86.8k - $165.2k / year
π° $200k Grant - RTX on 2024-11
β° Full Time
π΄ Lead
β¨ Principal
π₯ 8 hours ago
Managing Client Principal leading presales teams for healthcare digital solutions. Driving sales strategy, team mentorship, and technical excellence in digital and cloud technologies.
πΊπΈ United States β Remote
π° Private equity on 2011-05
β° Full Time
π΄ Lead
β¨ Principal
π¦ H1B Visa Sponsor
π₯ 9 hours ago
Managing Client Principal responsible for driving digital service sales and leading teams in healthcare solutions. Focused on application development and modernization with a strong emphasis on AI and data modernization.